Literature DB >> 28587373

Thrombophilia with an onset symptom of intracranial venous thrombosis: A case report and review of the literature.

Li Cui1, Lijun Zhu2, Yuting Wang1, Wuqiong Zhang1, Shaokuan Fang1.   

Abstract

Thrombophilia may be hereditary or acquired and is associated with a high risk of thrombosis. The diagnosis rate for thrombophilia is low, particularly for patients with non-specific symptoms. The present study describes a patient with thrombophilia, presenting with onset symptoms for intracranial venous thrombosis. The patient had increased serum homocysteine and anticardiolipin immunoglobulin G antibodies and decreased protein S activities. In addition, the patient was obese and had a one-week history of fatigue, immobilization and insufficient water intake. Radiological findings identified multiple venous thrombosis. Since the patient had multiple risk factors for thrombosis, the diagnosis of thrombophilia was made. No mutations with definite clinical significance were identified in the assessments for mutations of the protein S-α (PROS1) gene. The current case highlights the importance of correct diagnosis for thrombophilia in patients who present with the onset symptoms of intracranial venous thrombosis.

Entities:  

Keywords:  intracranial venous thrombosis; protein S alpha 1 gene; thrombophilia; venous thromboembolism

Year:  2017        PMID: 28587373      PMCID: PMC5450513          DOI: 10.3892/etm.2017.4316

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  21 in total

1.  A case-based reasoning view of thrombophilia risk.

Authors:  João Vilhena; Henrique Vicente; M Rosário Martins; José M Grañeda; Filomena Caldeira; Rodrigo Gusmão; João Neves; José Neves
Journal:  J Biomed Inform       Date:  2016-07-09       Impact factor: 6.317

2.  Concurrent Factor V Leiden and Protein C Deficiency Presenting as Mesenteric Venous Thrombosis.

Authors:  Lev N Korovin; Mustafa Raoof; John B Kettelle; James H McClenathan; Jitesh A Patel
Journal:  Am Surg       Date:  2016-04       Impact factor: 0.688

3.  On the natural blood coagulation inhibitor system. Investigations of inhibitor factors based on antithrombin deficient blood.

Authors:  O Egeberg
Journal:  Thromb Diath Haemorrh       Date:  1965-11-15

4.  Diagnostic issues in thrombophilia: a laboratory scientist's view.

Authors:  Emmanuel J Favaloro
Journal:  Semin Thromb Hemost       Date:  2005-02       Impact factor: 4.180

Review 5.  What is the optimal duration of treatment for DVT? An update on evidence-based medicine of treatment for DVT.

Authors:  Andrea T East; Thomas W Wakefield
Journal:  Semin Vasc Surg       Date:  2010-09       Impact factor: 1.000

Review 6.  Thromboembolism in pregnancy: recurrence risks, prevention and management.

Authors:  Andra H James
Journal:  Curr Opin Obstet Gynecol       Date:  2008-12       Impact factor: 1.927

7.  The association between Factor V Leiden with the presence and severity of coronary artery disease.

Authors:  Mohammadali Boroumand; Leila Pourgholi; Shayan Ziaee; Maryam Sotoudeh Anvari; Arash Jalali; Hamidreza Goodarzynejad
Journal:  Clin Biochem       Date:  2013-12-17       Impact factor: 3.281

Review 8.  Management of thrombophilia.

Authors:  K A Bauer
Journal:  J Thromb Haemost       Date:  2003-07       Impact factor: 5.824

9.  The prevalence of Factor V Leiden, prothrombin G20210A, MTHFR C677T and MTHFR A1298C mutations in healthy Turkish population.

Authors:  M Ekim; H Ekim; Y K Yılmaz
Journal:  Hippokratia       Date:  2015 Oct-Dec       Impact factor: 0.471

Review 10.  Antiphospholipid syndrome.

Authors:  M Khamashta; M Taraborelli; S Sciascia; A Tincani
Journal:  Best Pract Res Clin Rheumatol       Date:  2016-05-04       Impact factor: 4.098

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.